The economic management of congenital anomalies in Riyadh and throughout Saudi Arabia is characterized by high clinical complexity and substantial resource utilization. As the Kingdom shifts from focusing on infectious disease control to managing chronic, disabling conditions, the financial burden of birth defects—which occur in approximately 4.1% of Saudi newborns—has become a central public health concern.

1. Economic Burden on Families

The financial strain on families is significant, often consuming a large portion of household income. Recent studies focused on specific conditions like Down syndrome indicate that monthly care costs average approximately SAR 3,900 to SAR 4,200, consuming nearly 60% of the average household's monthly income.

• Key Cost Drivers: Medical expenses (accounting for roughly 40% of total costs) and daily care hours are the primary drivers of this expenditure.

• Urban-Rural Disparities: Rural families face disproportionately higher transportation costs (17% of total costs vs. 13% in urban areas) and experience greater difficulty in accessing therapy and specialized educational support.

• Insurance and Support: While insurance coverage is more prevalent in urban settings (86% vs. 77% in rural regions), government support remains a critical factor in reducing the absolute financial burden on families.

2. Clinical and Healthcare Resource Utilization

Riyadh’s tertiary care centers are leaders in managing complex structural and metabolic anomalies. However, the costs associated with these interventions vary widely based on the complexity of the condition and the intensity of the required care.

• Variable Treatment Costs: While specific surgical or clinical treatments for minor to moderate anomalies can range from SAR 4,999 to SAR 19,999, complex cases requiring neonatal intensive care (NICU) or long-term multidisciplinary intervention (such as spina bifida, which carries an estimated lifetime cost of roughly $560,000 USD) represent a much higher resource utilization burden.

• NICU Resources: Neonatal surgery is consistently identified as a high-cost area due to the necessity of NICU resources and the involvement of specialized sub-professionals.

• Management Strategies: Hospitals are increasingly adopting standardized Clinical Practice Guidelines (CPGs) to streamline care pathways, reduce diagnostic delays, and optimize the use of high-cost infrastructure.

3. Strategies for Economic and Clinical Efficiency

To mitigate the financial impact of congenital anomalies, the Saudi healthcare sector is focusing on:

• Centralized Registries: Developing a centralized database to monitor healthcare costs and service integration, which is a key objective under Vision 2030.

• Preventative Initiatives: Increasing public awareness and fostering engagement in preconception genetic screening to identify high-risk pregnancies early, thereby reducing the need for emergency, high-acuity neonatal interventions.

• Optimizing Care Pathways: Enhancing the integration of multidisciplinary teams—comprising geneticists, pediatric surgeons, and rehabilitation therapists—to improve long-term outcomes and minimize the "revolving door" of fragmented care.

Summary of Cost Factors

References

• Ministry of Health. (2025). Clinical practice guidelines for the detection, diagnosis of fetus and neonatal congenital anomaly. https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Pages/CA-pathway%20CPG-Final.pdf

• Al-Hassan, M. et al. (2025). Balancing costs and care: a healthcare cost analysis for families of children with Down syndrome in Saudi Arabia. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12644096/

• Al-Hamed, M. H., & Al-Amri, A. (2015). Epidemiology of neural tube defects in Saudi Arabia. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4362098/

• Al-Jassir, F. et al. (2019). Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6731804/